Recce Pharmaceuticals awarded A$11 million Advanced Overseas Finding for anti-viral R&D costs Posted on December 17, 2023September 25, 2024 by recce_com Recce Pharmaceuticals awarded A$11 million Advanced Overseas Finding for anti-viral R&D costs
Recce Pharmaceuticals awarded $43.7 million Advanced Overseas Finding for synthetic anti-infective development program Posted on December 15, 2023September 25, 2024 by recce_com Recce Pharmaceuticals awarded $43.7 million Advanced Overseas Finding for synthetic anti-infective development program
Recce Pharmaceuticals lead anti-infective R327 shows promise against deadly STD in latest animal study Posted on December 14, 2023September 25, 2024 by recce_com Recce Pharmaceuticals lead anti-infective R327 shows promise against deadly STD in latest animal study
Antimicrobial resistance with Recce Pharmaceuticals Posted on December 6, 2023September 25, 2024 by recce_com Antimicrobial resistance with Recce Pharmaceuticals
Engineering the future of antibiotics Posted on December 6, 2023September 25, 2024 by recce_com Engineering the future of antibiotics
Recce Pharmaceuticals wins Canadian patent for flagship anti-infectives Posted on November 23, 2023September 25, 2024 by recce_com Recce Pharmaceuticals wins Canadian patent for flagship anti-infectives
Recce Pharmaceuticals doses first patients over 15 minutes in R327 UTI/urosepsis trial Posted on November 7, 2023September 25, 2024 by recce_com Recce Pharmaceuticals doses first patients over 15 minutes in R327 UTI/urosepsis trial
Recce Pharmaceuticals completes dosing of first subjects at faster infusion rate in RECCE® 327 clinical trial Posted on November 7, 2023September 25, 2024 by recce_com Recce Pharmaceuticals completes dosing of first subjects at faster infusion rate in RECCE® 327 clinical trial
Recce Pharmaceuticals presents at Ord Minnett Healthcare Forum Posted on November 1, 2023September 25, 2024 by recce_com Recce Pharmaceuticals presents at Ord Minnett Healthcare Forum
Recce Pharma welcomes approval for faster RECCE327 infusion rate Posted on October 25, 2023September 25, 2024 by recce_com Recce Pharma welcomes approval for faster RECCE327 infusion rate
